Furthermore, GS-9820 did not influence maximal anti-CD20 mAb-mediated leukemia depletion 48 h post treatment of either Bim+/+ or Bim−/− leukemia-recipient animals (Figure 8a, right). This evidence concerns the gene BCL2L11 and leukemia.